Leptomeningeal disease from melanoma—Poor prognosis despite new therapeutic modalities

The development of leptomeningeal disease (LMD) among melanoma patients is associated with short survival. Unspecific clinical symptoms and imprecise diagnostic criteria often delay diagnosis. Because melanoma patients with LMD have been excluded from most clinical trials, the efficacy of immune che...

Ausführliche Beschreibung